Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/21/2007 | CN1301254C Preparation of catifloxacin and purifying method |
02/20/2007 | US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
02/20/2007 | US7179920 [4-(5-Chloro-2-hydroxy-phenyl)-2-oxo-6-trifluoromethyl- 1,2-dihydro-quinolin-3-ylsulfanyl]-acetic acid for example; potassium channel modulators for treating erectile dysfunction and irritable bowel syndrome |
02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
02/20/2007 | US7179816 Chemical derivatives and their application as antitelomerase agents |
02/20/2007 | US7179805 Microbiocides; bactericides |
02/20/2007 | US7179794 Antibiotics; bactericides |
02/20/2007 | CA2230770C Amidophosphinephosphinite compounds |
02/15/2007 | WO2007017414A1 Substituted malononitrile compounds for combating animal pests |
02/15/2007 | WO2006113606A3 Histone deacetylase inhibitors |
02/15/2007 | WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
02/15/2007 | US20070037976 Method for producing an optically active nitro compound |
02/15/2007 | US20070037849 1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea; angiogenesis neoplasia |
02/15/2007 | US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists. |
02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
02/14/2007 | EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
02/14/2007 | EP1751115A1 Theramutein modulators |
02/14/2007 | EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
02/14/2007 | EP1751086A2 DIAMINE ß2 ADRENERGIC RECEPTOR AGONISTS |
02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
02/14/2007 | EP1017676B1 Method for the synthesis of quinoline derivatives |
02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
02/14/2007 | CN1914206A 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
02/14/2007 | CN1914195A Substituted quinoline compounds |
02/14/2007 | CN1914176A Process for preparing aripiprazole |
02/14/2007 | CN1914175A Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
02/14/2007 | CN1914174A Methods of preparing aripiprazole crystalline forms |
02/14/2007 | CN1914173A Quinolines useful in treating cardiovascular disease |
02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
02/13/2007 | US7176315 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer |
02/13/2007 | US7176314 Inflammation modulators |
02/13/2007 | US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
02/13/2007 | US7176206 Antibiotics |
02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
02/13/2007 | CA2122236C Quinolines and their analogs |
02/08/2007 | WO2007016609A2 Method for the synthesis of quinoliνe derivatives |
02/08/2007 | WO2007015567A1 Cyclic amine compound |
02/08/2007 | WO2007014941A2 Quinoline derivatives as antibacterial agents |
02/08/2007 | WO2007014885A1 Antibacterial quinoline derivatives |
02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
02/08/2007 | WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
02/08/2007 | US20070032505 Crystalline form of gatifloxacin |
02/08/2007 | US20070032504 Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
02/08/2007 | US20070032474 Use of a compound of formula 1 for making a pharmaceutical composition |
02/08/2007 | CA2617256A1 Cyclic amine compound |
02/08/2007 | CA2616682A1 Squaric acid derivatives as protein kinase inhibitors |
02/08/2007 | CA2615903A1 Quinoline derivatives as antibacterial agents |
02/08/2007 | CA2615901A1 Quinoline derivatives as antibacterial agents |
02/08/2007 | CA2614981A1 Antibacterial quinoline derivatives |
02/07/2007 | EP1748987A2 2-propene-1-ones as hsp 70 inducers |
02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
02/07/2007 | CN1910181A Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
02/07/2007 | CN1910172A 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
02/07/2007 | CN1910154A Quinoline derivatives for use as mycobacterial inhibitors |
02/07/2007 | CN1910153A Derivatives of pyridine and quinoline |
02/07/2007 | CN1910137A Aryl aniline derivatives as beta2 adrenergic receptor agonists |
02/07/2007 | CN1909907A Quinoline derivatives and use thereof as mycobacterial inhibitors |
02/06/2007 | US7173136 3-Cyano-quinoline derivatives |
02/06/2007 | US7173135 Substituted 3-cyanoquinolines as MEK inhibitors |
02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
02/06/2007 | US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
02/06/2007 | US7173035 Arylsulfonamide compounds |
02/01/2007 | US20070027318 Quinoline derivatives and quinazoline derivatives |
02/01/2007 | US20070027184 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
02/01/2007 | US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
02/01/2007 | US20070027139 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders |
02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
01/31/2007 | EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders |
01/31/2007 | EP1747066A1 Collector for sulfidic ores |
01/31/2007 | EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use |
01/31/2007 | CN1906169A Therapeutic agents I |
01/31/2007 | CN1906168A Methods and compositions for selectin inhibition |
01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
01/31/2007 | CN1297542C Process for preparation of 6-fluoro-1,4-dihydro-4-oxo quinoline-3-carboxylic acid derivatives |
01/31/2007 | CN1297541C Method for preparing CETP inhibitors |
01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
01/30/2007 | US7169789 Quinoline derivatives and quinazoline derivatives |
01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |